The authorisation holder has an organisation that ensures that each patient receives treatment that complies with the recommendations or guidelines for good clinical practice defined by the National Cancer Institute, the Haute Autorité de Santé, the Agence Nationale de Sécurité du Médicament et des Produits de Santé, the Agence de la Biomédecine and, failing this, with recommendations that are the subject of a consensus by learned societies.